To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SIRT5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
237 supporting clones for gene SIRT5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR606976 B cells (Ramos cell line) Cot 25-normalized .a 1 to 1649 1 to 1649 exact tiling clone,   1649/1649
(100 %)
0 diff
(100 %id)
BX364410   .a 2 to 920 1 to 919   fully sequenced,   919/919
(100 %)
6 diff
(99.4 %id)
BX364409   .a 859 to 1649 791 to 1   fully sequenced,   791/791
(100 %)
3 diff
(99.7 %id)
CB155518 brain .b 1 to 652 1 to 652   tiling clone,   652/652
(100 %)
2 diff
(99.7 %id)
DC342893 thalamus .b 57 to 622 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC400520 testis .b 66 to 640 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
DA429942 colon .b 68 to 645 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA607563   .b 68 to 613 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA122983 cerebellum .b 72 to 639 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA193834 amygdala .b 72 to 639 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA234245 brain .b 72 to 648 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA421963 cervix .b 72 to 658 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA631644 Kidney .b 72 to 659 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA190264 amygdala .b 74 to 667 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DA233983 brain .b 74 to 656 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA236237 brain .b 74 to 661 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA542156 lung .b 74 to 666 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA810907 brain .b 74 to 632 2 to 560   capped   559/560
(99 %)
1 diff
(99.9 %id)
DT217646 brain .b 75 to 708 1 to 633       633/633
(100 %)
2 diff
(99.7 %id)
R83480 liver and spleen .b 86 to 549 8 to 480       473/482
(98 %)
17 diff
(96.5 %id)
CR595911 Neuroblastoma Cot 25-normalized .b 94 to 1636 1 to 1543 exact tiling clone,   1543/1543
(100 %)
0 diff
(100 %id)
CR617335 Neuroblastoma Cot 10-normalized .b 94 to 1620 1 to 1527 exact     1527/1527
(100 %)
0 diff
(100 %id)
AL522139 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 94 to 932 1 to 839   fully sequenced,   839/839
(100 %)
2 diff
(99.8 %id)
BX353902 Neuroblastoma Cot 25-normalized .b 94 to 938 1 to 844   fully sequenced,   844/844
(100 %)
0 diff
(100 %id)
BX459280 placenta .b 94 to 646 1 to 553   fully sequenced,   553/553
(100 %)
13 diff
(97.7 %id)
AL557465 T cells (Jurkat cell line), T cells from T cell leukemia .b 94 to 767 1 to 673       673/673
(100 %)
3 diff
(99.6 %id)
BX434479 placenta .b 623 to 1518 898 to 4   fully sequenced,   895/898
(99 %)
10 diff
(98.9 %id)
AL522138 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 877 to 1596 746 to 26   fully sequenced,   721/746
(96 %)
2 diff
(99.8 %id)
BX353901 Neuroblastoma Cot 25-normalized .b 877 to 1636 760 to 1   fully sequenced,   760/760
(100 %)
4 diff
(99.5 %id)
AL579496 T cells (Jurkat cell line), T cells from T cell leukemia .b 882 to 1595 720 to 7       714/720
(99 %)
3 diff
(99.6 %id)
DC314190 amygdala .c 1 to 557 1 to 557   tiling clone,   557/557
(100 %)
2 diff
(99.7 %id)
CR619396 Placenta Cot 25-normalized .c 5 to 1516 1 to 1512 exact tiling clone,   1512/1512
(100 %)
0 diff
(100 %id)
BX339959 Placenta Cot 25-normalized .c 5 to 817 1 to 812   fully sequenced,   814/814
(100 %)
7 diff
(99.2 %id)
AV659384 corresponding non cancerous liver tissue .c 10 to 405 1 to 396     Submitted on the opposite strand 396/396
(100 %)
2 diff
(99.5 %id)
BC000126 Eye, retinoblastoma .c 17 to 1668 1 to 1652 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1652/1652
(100 %)
1 diff
(100.0 %id)
NM_012241.3   .c 17 to 3931 1 to 3915 exact RefSeq, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3915/3915
(100 %)
0 diff
(100 %id)
BE256799 eye, retinoblastoma .c 38 to 748 1 to 707       707/732
(96 %)
19 diff
(97.5 %id)
AF083110 testis .c 40 to 1672 1 to 1633 exact     1633/1633
(100 %)
8 diff
(99.6 %id)
W23455 parathyroid gland, parathyroid tumor .c 40 to 585 1 to 557       557/557
(100 %)
25 diff
(95.6 %id)
CR600455 T cells (Jurkat cell line) .c 123 to 1562 1 to 1440 exact     1440/1440
(100 %)
0 diff
(100 %id)
CD633042   .c 209 to 987 778 to 1       778/778
(100 %)
2 diff
(99.8 %id)
TI_154177586   .c 280 to 1067 71 to 856       786/793
(99 %)
38 diff
(95.3 %id)
TI_154177778   .c 280 to 1137 69 to 911   AAA   843/923
(91 %)
38 diff
(95.9 %id)
TI_154170566   .c 427 to 1025 76 to 681       606/932
(65 %)
21 diff
(97.8 %id)
TI_154170609   .c 428 to 965 81 to 621       541/982
(55 %)
11 diff
(98.9 %id)
CR623350 T cells (Jurkat cell line) .c 465 to 1616 1 to 1152       1152/1152
(100 %)
0 diff
(100 %id)
AL557205 T cells (Jurkat cell line), T cells from T cell leukemia .c 465 to 960 1 to 496   fully sequenced,   496/496
(100 %)
1 diff
(99.8 %id)
CD633041   .c 489 to 951 1 to 461       461/472
(97 %)
8 diff
(98.4 %id)
CD633040   .c 490 to 935 469 to 17       461/470
(98 %)
12 diff
(97.5 %id)
BF112033 pooled .c 652 to 1290 651 to 13   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 639/639
(100 %)
13 diff
(98.0 %id)
AA341308 Kidney .c 668 to 978 1 to 311       311/311
(100 %)
2 diff
(99.4 %id)
BX435990 T cells (Jurkat cell line) .c 681 to 1545 888 to 18   AAA   871/885
(98 %)
35 diff
(96.1 %id)
BQ348311 head_neck .c 719 to 1325 19 to 627       609/639
(95 %)
13 diff
(98.0 %id)
BX339958 Placenta Cot 25-normalized .c 757 to 1516 764 to 1   fully sequenced,   739/739
(100 %)
16 diff
(97.9 %id)
BU631239 cell lines, Chondrosarcoma .c 839 to 1545 722 to 19   AAA   704/704
(100 %)
4 diff
(99.5 %id)
CA429051 Cell Line, Chondrosarcoma .c 877 to 1545 684 to 19   AAA   666/670
(99 %)
6 diff
(99.2 %id)
CD368433 Alveolar Macrophage, lung .c 880 to 1545 683 to 19   AAA   665/665
(100 %)
1 diff
(99.9 %id)
CV335046 uterus_tumor .c 882 to 1353 1 to 472       472/472
(100 %)
4 diff
(99.2 %id)
CV335048 uterus_tumor .c 886 to 1370 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
AL579291 T cells (Jurkat cell line), T cells from T cell leukemia .c 899 to 1616 718 to 1   fully sequenced,   718/718
(100 %)
19 diff
(97.4 %id)
NM_031244.2   .d 1 to 2377 1 to 2377 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 2377/2377
(100 %)
0 diff
(100 %id)
BU602841 mixed (pool of 40 RNAs) .d 29 to 871 1 to 839   tiling clone,   839/839
(100 %)
17 diff
(98.0 %id)
DA682787   .d 35 to 820 2 to 784   capped   783/795
(98 %)
5 diff
(99.4 %id)
AJ420496   .d 41 to 2377 1 to 2337 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 2337/2337
(100 %)
6 diff
(99.8 %id)
AK000355   .d 42 to 2377 1 to 2332 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 2332/2332
(100 %)
5 diff
(99.8 %id)
BU181083 embryonal carcinoma, cell line, testis .d 52 to 886 1 to 835       835/875
(95 %)
10 diff
(98.9 %id)
BU195560 eye, retinoblastoma .d 52 to 886 12 to 857       846/901
(93 %)
19 diff
(97.9 %id)
CD633043   .d 55 to 873 1 to 822       820/822
(99 %)
10 diff
(98.8 %id)
AA383587 testis .d 908 to 1218 1 to 312       312/316
(98 %)
11 diff
(96.6 %id)
BE379900 bladder, carcinoma, cell line .d 1155 to 1747 1 to 592   fully sequenced,   592/592
(100 %)
0 diff
(100 %id)
N77226 liver and spleen .d 1175 to 1439 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
R05372 liver and spleen .d 1177 to 1471 1 to 307       307/307
(100 %)
16 diff
(94.8 %id)
CR741134 pooled .d 1300 to 2099 1 to 805       805/806
(99 %)
6 diff
(99.3 %id)
H19691 brain .d 1427 to 1861 1 to 440       440/440
(100 %)
6 diff
(98.7 %id)
H49296 brain .d 1427 to 1913 1 to 496       496/498
(99 %)
15 diff
(97.0 %id)
BQ311884 breast_normal .d 1573 to 1943 379 to 7       373/379
(98 %)
0 diff
(100 %id)
BQ311883 breast_normal .d 1581 to 1942 367 to 4       364/367
(99 %)
0 diff
(100 %id)
BQ372846 prostate_tumor .d 1581 to 1943 368 to 7       362/368
(98 %)
3 diff
(99.2 %id)
AW936770 denis_drash .d 1589 to 1909 1 to 320       320/320
(100 %)
1 diff
(99.7 %id)
TI_154046401   .d 1638 to 2377 827 to 88   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 740/977
(75 %)
0 diff
(100 %id)
CA412315 Chondrosarcoma Grade II, Left Pelvis .d 1638 to 2377 758 to 19   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 740/750
(98 %)
0 diff
(100 %id)
BE379830 bladder, carcinoma, cell line .d 1717 to 2311 622 to 18   fully sequenced,   605/622
(97 %)
6 diff
(99.1 %id)
DB322598   .d 1887 to 2377 491 to 1       491/493
(99 %)
0 diff
(100 %id)
N55168 liver and spleen .d 1930 to 2379 450 to 1       450/451
(99 %)
2 diff
(99.6 %id)
BE350936 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1938 to 2096 159 to 1       159/159
(100 %)
0 diff
(100 %id)
DB561777 hypothalamus .d 1945 to 2375 1 to 431     Submitted on the opposite strand 431/433
(99 %)
5 diff
(98.9 %id)
H19692 brain .d 1949 to 2371 433 to 5       429/439
(97 %)
0 diff
(100 %id)
BF508000   .d 1954 to 2377 441 to 18   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 424/424
(100 %)
2 diff
(99.6 %id)
AI620794 Prostate .d 2016 to 2378 363 to 1       363/363
(100 %)
5 diff
(98.7 %id)
AI269430 Kidney .d 2045 to 2379 335 to 1       335/335
(100 %)
0 diff
(100 %id)
BU689771 Human Lung Epithelial cells, lung .d 2122 to 2377 274 to 19   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 256/265
(96 %)
1 diff
(99.7 %id)
AL542425 placenta .e 1 to 936 1 to 931   tiling clone,   931/934
(99 %)
6 diff
(99.4 %id)
CR976296 T-Lymphocytes .e 815 to 1519 1 to 708   tiling clone,   708/708
(100 %)
4 diff
(99.5 %id)
CA406695 adipose .f 1 to 342 1 to 342   tiling clone,   342/342
(100 %)
0 diff
(100 %id)
NM_001193267.1   .f 1 to 3831 1 to 3831 exact RefSeq,   3831/3831
(100 %)
0 diff
(100 %id)
AK302467 testis .f 35 to 1562 1 to 1528 I53M tiling clone,   1528/1528
(100 %)
2 diff
(99.9 %id)
BM543254 embryonal carcinoma, cell line, testis .f 38 to 735 1 to 698       698/1089
(64 %)
8 diff
(99.3 %id)
DB491312 hypothalamus .f 39 to 195 1 to 157       157/157
(100 %)
2 diff
(98.8 %id)
DB448647 testis .f 40 to 283 1 to 245       245/247
(99 %)
4 diff
(98.4 %id)
AL704940 human skeletal muscle .f 42 to 296 1 to 255       255/255
(100 %)
0 diff
(100 %id)
CD652656 Embryonic Stem cells .f 42 to 817 54 to 821       768/882
(87 %)
16 diff
(98.2 %id)
DA998289   .f 43 to 300 2 to 259   capped   258/258
(100 %)
1 diff
(99.7 %id)
DT217863 brain .f 44 to 763 1 to 720       720/720
(100 %)
0 diff
(100 %id)
BI763271 pooled colon, kidney, stomach .f 63 to 776 10 to 724       715/729
(98 %)
9 diff
(98.8 %id)
TI_57150103   .f 63 to 776 39 to 753       715/758
(94 %)
9 diff
(98.9 %id)
W73222 heart .f 70 to 671 1 to 592       592/603
(98 %)
13 diff
(97.9 %id)
DB274050 uterus .f 71 to 615 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BX462468 T cells (Jurkat cell line) .f 105 to 771 36 to 701       666/701
(95 %)
50 diff
(92.9 %id)
N28346 melanocyte .f 115 to 495 1 to 388       388/393
(98 %)
11 diff
(97.3 %id)
CX868353 embryonic stem .f 134 to 827 1 to 694   tiling clone,   694/694
(100 %)
0 diff
(100 %id)
DA183555 amygdala .f 146 to 633 2 to 489   capped   488/488
(100 %)
1 diff
(99.8 %id)
W68574 heart .f 189 to 631 1 to 446       446/448
(99 %)
12 diff
(97.4 %id)
CD556673 brain, Pituitary .f 196 to 735 7 to 557       551/1067
(51 %)
33 diff
(97.0 %id)
CF145377 CNCAP(3)T-225 cell line, Prostate .f 227 to 788 8 to 569       562/569
(98 %)
15 diff
(97.4 %id)
CF145541 CNCAP(3)T-225 cell line, Prostate .f 227 to 814 8 to 595       588/596
(98 %)
11 diff
(98.2 %id)
CF140176 CNCAP(3)T-225 cell line, Prostate .f 375 to 802 9 to 436       428/436
(98 %)
0 diff
(100 %id)
CF140179 CNCAP(3)T-225 cell line, Prostate .f 375 to 810 9 to 444       436/444
(98 %)
4 diff
(99.1 %id)
AI559256 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 839 to 1372 538 to 5       534/538
(99 %)
3 diff
(99.5 %id)
AI817797 normal prostate, Prostate .f 839 to 1440 602 to 1       602/602
(100 %)
2 diff
(99.7 %id)
BF056383 pooled germ cell tumors .f 863 to 1564 698 to 1       699/698
(100 %)
45 diff
(93.6 %id)
BF591323 colon, colon tumor, RER+ .f 878 to 1446 569 to 1       569/569
(100 %)
8 diff
(98.6 %id)
BU630157 cell lines, Chondrosarcoma .f 901 to 1561 675 to 16   AAA   660/660
(100 %)
2 diff
(99.7 %id)
AW974310   .f 911 to 1368 458 to 1     Submitted on the opposite strand 458/571
(80 %)
2 diff
(99.7 %id)
W72957 heart .f 916 to 1446 526 to 2       525/528
(99 %)
8 diff
(98.5 %id)
TI_44159676   .f 917 to 1438 26 to 547   AAA   522/547
(95 %)
8 diff
(98.6 %id)
BI523790 pooled lung and spleen .f 920 to 1438 1 to 519   fully sequenced, AAA   519/519
(100 %)
2 diff
(99.7 %id)
AA811503 germinal center B cell .f 923 to 1369 466 to 20   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
BI062850 uterus_tumor .f 932 to 1471 540 to 1       540/540
(100 %)
4 diff
(99.3 %id)
AA760845 germinal center B cell .f 951 to 1369 428 to 11   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 418/418
(100 %)
1 diff
(99.8 %id)
BX099739 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 955 to 1369 429 to 15   AAA Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
CX868278 embryonic stem .f 968 to 1556 618 to 30   AAA   589/589
(100 %)
1 diff
(99.9 %id)
CB851527 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 988 to 1438 469 to 19   AAA   451/451
(100 %)
8 diff
(98.3 %id)
BQ006251 Chondrosarcoma, Left Pelvis .f 995 to 1565 589 to 19   AAA   571/571
(100 %)
0 diff
(100 %id)
AA812245 invasive tumor (cell line), Prostate .f 1019 to 1369 352 to 1       352/352
(100 %)
2 diff
(99.5 %id)
BI524629 pooled lung and spleen .f 1032 to 1365 345 to 9   fully sequenced,   337/345
(97 %)
1 diff
(99.8 %id)
DB513787 testis .f 1042 to 1438 1 to 395     Submitted on the opposite strand 395/395
(100 %)
4 diff
(99.0 %id)
AI089886 brain, glioblastoma (pooled) .f 1058 to 1448 396 to 6       391/408
(95 %)
0 diff
(100 %id)
AI580681 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 1058 to 1372 318 to 4       315/320
(98 %)
0 diff
(100 %id)
AI674666 pooled .f 1058 to 1562 507 to 3       505/510
(99 %)
0 diff
(100 %id)
TI_149311873   .f 1058 to 1438 466 to 86   AAA   381/951
(40 %)
6 diff
(99.4 %id)
BF434883 Kidney .f 1090 to 1558 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI312117 lung .f 1092 to 1557 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AI419476 brain, glioblastoma (pooled) .f 1092 to 1438 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AI671353 Kidney .f 1092 to 1438 362 to 16   AAA   347/351
(98 %)
2 diff
(99.5 %id)
T48877 placenta .f 1095 to 1543 1 to 449       449/451
(99 %)
14 diff
(96.9 %id)
AA765055 germinal center B cell .f 1098 to 1369 284 to 13   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 272/272
(100 %)
0 diff
(100 %id)
AA732428 germinal center B cell .f 1104 to 1369 285 to 20   AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 266/266
(100 %)
0 diff
(100 %id)
AW169965 pooled .f 1111 to 1562 453 to 2       452/453
(99 %)
0 diff
(100 %id)
AA721145 germinal center B cell .f 1148 to 1445 316 to 19   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 298/300
(99 %)
0 diff
(100 %id)
AI811882 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1164 to 1565 415 to 14   AAA   402/402
(100 %)
2 diff
(99.6 %id)
AI424549 Prostate .f 1195 to 1438 245 to 1       245/246
(99 %)
1 diff
(99.6 %id)
AI864632 pooled .f 1195 to 1562 372 to 5       368/372
(98 %)
0 diff
(100 %id)
AW002193 thymus, pooled .f 1195 to 1561 367 to 1       367/368
(99 %)
0 diff
(100 %id)
BE932108 head_neck .f 1230 to 1562 1 to 333       333/336
(99 %)
2 diff
(99.5 %id)
BE932117 head_neck .f 1230 to 1557 1 to 328       328/328
(100 %)
1 diff
(99.7 %id)
DA305608 hippocampus .f 1234 to 1792 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
AW129622 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1273 to 1562 293 to 4       290/293
(98 %)
0 diff
(100 %id)
W68575 heart .f 1307 to 1565 259 to 1       259/259
(100 %)
0 diff
(100 %id)
AW235778 pooled germ cell tumors .f 1344 to 1564 221 to 1       221/221
(100 %)
3 diff
(98.7 %id)
EC528867 Prostate .f 1351 to 1441 1 to 90       90/90
(100 %)
1 diff
(98.9 %id)
DR003695 hippocampus .f 1442 to 1933 9 to 502   tiling clone,   494/502
(98 %)
6 diff
(98.9 %id)
BF942991 nervous_normal .f 1476 to 1972 498 to 6   tiling clone, Submitted on the opposite strand 493/498
(98 %)
0 diff
(100 %id)
FN157179 breast carcinoma .f 1476 to 1557 86 to 7     Submitted on the opposite strand 80/86
(93 %)
0 diff
(100 %id)
BF944618 nervous_normal .f 1499 to 1962 466 to 5     Submitted on the opposite strand 462/473
(97 %)
0 diff
(100 %id)
AK094269 cerebellum .f 1572 to 3824 1 to 2255   tiling clone, available from FLJ,   2255/2255
(100 %)
1 diff
(100.0 %id)
DA058070 cerebellum .f 1573 to 2159 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DC324403 brain .g 1 to 581 1 to 581   tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
DC310274 cerebellum .g 51 to 617 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
DA407470 thalamus .g 77 to 632 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
BG702042 brain, hippocampus .g 83 to 782 1 to 705   tiling clone,   705/814
(86 %)
14 diff
(98.3 %id)
BG741528 skin .g 96 to 1016 1 to 928 W77X K148R A149L G150A T151P ... tiling clone,   926/931
(99 %)
29 diff
(96.9 %id)
DC309997 cerebellum .h 1 to 559 1 to 559   tiling clone,   559/559
(100 %)
1 diff
(99.9 %id)
AI913731 Kidney .h 395 to 936 541 to 1   tiling clone,   541/541
(100 %)
1 diff
(99.9 %id)
BX538030 human endometrium carcinoma cell line .i 1 to 1336 1 to 1336 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1336/1336
(100 %)
2 diff
(99.9 %id)
TI_57239097   .i 2 to 791 31 to 817       787/817
(96 %)
10 diff
(98.8 %id)
BI915085 brain .i 8 to 791 1 to 781       781/781
(100 %)
3 diff
(99.7 %id)
AK294162 amygdala .i 20 to 1044 1 to 1025 exact tiling clone,   1025/1025
(100 %)
1 diff
(100.0 %id)
DC312917 amygdala .i 20 to 591 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
DB135180 thymus .i 21 to 466 2 to 447   capped   446/446
(100 %)
0 diff
(100 %id)
DB215013 trachea .i 21 to 569 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DC393485 cervix, tumor tissue .j 1 to 560 1 to 561   tiling clone,   561/561
(100 %)
4 diff
(99.3 %id)
BE747305 adenocarcinoma cell line, ovary .j 495 to 1133 1 to 639   tiling clone,   639/639
(100 %)
0 diff
(100 %id)
DN994131 brain, whole brain .k-u 1 to 588 9 to 596   tiling clone,   588/596
(98 %)
6 diff
(99.0 %id)
BC035122 Brain, hippocampus .k-u 233 to 2639 1 to 2407 Y44C N114D tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 2407/2407
(100 %)
7 diff
(99.8 %id)
BC035196.
matches multiple genes
brain, Brain, hippocampus, hippocampus .k-u 233 to 2639 1 to 2407   available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base), also hits gene FBLN2 2407/2407
(100 %)
7 diff
(99.8 %id)
R52753 whole brain .k-u 270 to 639 375 to 1     Submitted on the opposite strand 375/607
(61 %)
12 diff
(98.1 %id)
BI549527 brain, hippocampus .k-u 520 to 949 299 to 734   available from MGC,   708/734
(96 %)
24 diff
(96.8 %id)
TI_44169350   .k-u 520 to 949 413 to 848       705/848
(83 %)
18 diff
(97.9 %id)
BQ230580 epithelioid carcinoma, Pancreas .l 1 to 609 2 to 610 exact tiling clone,   610/614
(99 %)
1 diff
(99.9 %id)
BG911423 anaplastic oligodendroglioma with 1p/19qloss, brain .m 1 to 603 4 to 606 exact tiling clone,   606/606
(100 %)
2 diff
(99.7 %id)
DA345102 substantia nigra .n-u 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
3 diff
(99.5 %id)
AV646758 corresponding non cancerous liver tissue .n-u 33 to 436 1 to 404     Submitted on the opposite strand 404/404
(100 %)
4 diff
(99.1 %id)
AV646797 corresponding non cancerous liver tissue .n-u 33 to 436 1 to 404   tiling clone, Submitted on the opposite strand 404/404
(100 %)
0 diff
(100 %id)
BE061705 breast .n-u 293 to 545 254 to 1     Submitted on the opposite strand 254/254
(100 %)
2 diff
(99.3 %id)
BE147357 head_neck .n-u 323 to 546 1 to 224       224/224
(100 %)
8 diff
(96.5 %id)
R07550 liver and spleen .n-u 375 to 736 395 to 22   tiling clone, Submitted on the opposite strand 374/399
(93 %)
0 diff
(100 %id)
F08387 brain, total brain .n-u 520 to 779 1 to 260       260/260
(100 %)
1 diff
(99.7 %id)
R61118 whole brain .n-u 521 to 947 1 to 441   tiling clone,   441/446
(98 %)
22 diff
(95.1 %id)
BU626504 Alveolar Macrophage, lung .n-u 903 to 1584 698 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 682/682
(100 %)
1 diff
(99.9 %id)
AW300473 Kidney .n-u 940 to 1579 640 to 1       640/642
(99 %)
16 diff
(97.6 %id)
AA232984 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n-u 967 to 1241 1 to 275   tiling clone,   275/275
(100 %)
2 diff
(99.3 %id)
BX117637 whole brain .n-u 1507 to 2028 536 to 15   AAA   522/522
(100 %)
1 diff
(99.9 %id)
AI829422 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n-u 1544 to 2036 494 to 2   tiling clone,   493/494
(99 %)
0 diff
(100 %id)
AW195061 Kidney .n-u 1569 to 2034 467 to 1       467/471
(99 %)
18 diff
(96.2 %id)
TI_157602723   .n-u 1587 to 2229 708 to 67       642/1150
(55 %)
0 diff
(100 %id)
TI_157602252   .n-u 1637 to 2229 665 to 70       596/1151
(51 %)
0 diff
(100 %id)
AW044163 pooled .n-u 1638 to 2036 400 to 2       399/400
(99 %)
0 diff
(100 %id)
AI969140 brain, four pooled pituitary adenomas .n-u 1641 to 2029 401 to 13   AAA   389/389
(100 %)
0 diff
(100 %id)
TI_157602518   .n-u 1665 to 2229 621 to 58       564/621
(90 %)
0 diff
(100 %id)
R61840 whole brain .n-u 1680 to 2036 369 to 2       368/373
(98 %)
0 diff
(100 %id)
AI697770 carcinoid, lung .n-u 1688 to 2223 533 to 1   tiling clone,   533/533
(100 %)
5 diff
(99.1 %id)
AW300354 Kidney .n-u 1690 to 2031 342 to 1       342/342
(100 %)
6 diff
(98.3 %id)
AI797212 colon .n-u 1717 to 2223 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
AI824101 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .n-u 1737 to 2198 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AA233370 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n-u 1756 to 2029 274 to 1       274/274
(100 %)
0 diff
(100 %id)
AW592790 pooled .n-u 1761 to 2033 273 to 1       273/273
(100 %)
0 diff
(100 %id)
Z41384 brain, total brain .n-u 1767 to 2029 263 to 1       263/263
(100 %)
0 diff
(100 %id)
DA072677 cerebellum .o 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
DB135138 thymus .o 15 to 538 2 to 526   capped   525/539
(97 %)
2 diff
(99.7 %id)
CA311232 Human Lung Epithelial cells, lung .o 199 to 912 732 to 19 E47G tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 714/714
(100 %)
4 diff
(99.5 %id)
DB297599 cerebellum .o 2028 to 2555 528 to 1   tiling clone,   528/528
(100 %)
1 diff
(99.9 %id)
DA021072   .p 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
AW814993 stomach .p 269 to 915 1 to 644   tiling clone,   644/647
(99 %)
14 diff
(97.9 %id)
CV312572 uterus_tumor .p 673 to 904 248 to 16   tiling clone, Submitted on the opposite strand 233/260
(89 %)
0 diff
(100 %id)
TI_149288954   .q-u 1 to 878 914 to 46 C18R tiling clone,   869/914
(95 %)
31 diff
(96.7 %id)
FN150271 breast carcinoma .q-u 136 to 208 1 to 73   tiling clone,   73/74
(98 %)
3 diff
(96.0 %id)
BM970659 lung .q-u 182 to 836 673 to 19 C18R tiling clone, AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 655/655
(100 %)
3 diff
(99.6 %id)
AI760662 B-cell, chronic lymphotic leukemia .q-u 443 to 838 396 to 1       396/396
(100 %)
6 diff
(98.5 %id)
AI470861 Kidney .q-u 567 to 836 270 to 1       270/274
(98 %)
2 diff
(99.3 %id)
CB069487 Pancreas, Purified pancreatic islet .q-u 647 to 859 1 to 213   tiling clone,   213/213
(100 %)
0 diff
(100 %id)
BX641656   .r-u 1 to 642 1 to 641 exact tiling clone,   641/644
(99 %)
6 diff
(99.1 %id)
DB011874 esophageal, tumor tissue .r-u 181 to 744 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
AA828875 ovary .r-u 538 to 829 317 to 26   tiling clone,   292/317
(92 %)
0 diff
(100 %id)
AI401136 B-cell, chronic lymphotic leukemia .s-u 1 to 398 1 to 398   tiling clone, Submitted on the opposite strand 398/398
(100 %)
0 diff
(100 %id)
AI923092 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .s-u 328 to 808 492 to 12   tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 481/481
(100 %)
7 diff
(98.6 %id)
BE217845 carcinoid, lung .s-u 383 to 766 384 to 1   tiling clone,   384/384
(100 %)
0 diff
(100 %id)
BE163884 head_neck .t-u 1 to 358 358 to 1   tiling clone, Submitted on the opposite strand 358/358
(100 %)
1 diff
(99.8 %id)
DB471948.
matches multiple genes
hippocampus .t-u 109 to 602 1 to 494     also hits gene snorgleybu 494/494
(100 %)
2 diff
(99.6 %id)
CD722841 eye, lacrimal gland .t-u 127 to 749 1 to 622 K36X I43* tiling clone,   622/622
(100 %)
1 diff
(99.9 %id)
DC333228 hippocampus .t-u 148 to 717 1 to 569       569/569
(100 %)
6 diff
(99.0 %id)
AV646251 corresponding non cancerous liver tissue .t-u 165 to 607 1 to 444     Submitted on the opposite strand 444/444
(100 %)
5 diff
(98.9 %id)
DC336305 hippocampus .u 1 to 588 1 to 588 exact tiling clone,   588/588
(100 %)
13 diff
(97.8 %id)
DA256187 caudate nucleus .u 17 to 586 2 to 571 exact tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
DA102263 cerebellum .u 19 to 580 2 to 563 exact tiling clone, capped   562/562
(100 %)
3 diff
(99.5 %id)
DA217342 brain .va 1 to 542 2 to 543 Q57R T79A tiling clone, capped   542/542
(100 %)
3 diff
(99.5 %id)
BI063684 uterus_tumor .va 113 to 376 1 to 264   tiling clone,   264/265
(99 %)
10 diff
(96.3 %id)
DC394156 esophageal, tumor tissue .vb 1 to 533 1 to 534 K79E R97P V98G W99V E100G tiling clone,   534/535
(99 %)
3 diff
(99.5 %id)
BI061941 uterus_tumor .vc 1 to 490 1 to 490 exact tiling clone,   490/490
(100 %)
0 diff
(100 %id)
AI963044 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vd-u 1 to 459 472 to 13 I19N G20R S21K S23F E24R ... tiling clone,   460/472
(97 %)
0 diff
(100 %id)
Z17867   .vd-u 155 to 479 325 to 1 exact tiling clone,   325/325
(100 %)
0 diff
(100 %id)
AW387743 stomach .ve-u 1 to 267 1 to 266 K2Q L13Y L14* tiling clone,   266/266
(100 %)
5 diff
(98.2 %id)
AA680399 liver and spleen .vf-u 1 to 231 231 to 1 W58S tiling clone,   231/231
(100 %)
1 diff
(99.6 %id)
DB298128 cerebellum Gene SIRT5, variant not shown         This clone was ignored    
DA086278 cerebellum Gene SIRT5, variant not shown       capped This clone was ignored    
DB315146 brain Gene SIRT5, variant not shown              
DA485133 brain Gene SIRT5, variant not shown       capped      
AV646270 corresponding non cancerous liver tissue Gene SIRT5, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
R07497 liver and spleen Gene SIRT5, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n-u, .o, .p, .q-u, .r-u, .s-u, .t-u, .u, .va, .vb, .vc, .vd-u, .ve-u, .vf-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C